HDAC-6 inhibition ameliorates the early neuropathology in a mouse model of Krabbe disease
IntroductionIn Krabbe disease (KD), mutations in β-galactosylceramidase (GALC), a lysosomal enzyme responsible for the catabolism of galactolipids, leads to the accumulation of its substrates galactocerebroside and psychosine. This neurologic condition is characterized by a severe and progressive de...
Päätekijät: | , , , , , , , , |
---|---|
Aineistotyyppi: | Artikkeli |
Kieli: | English |
Julkaistu: |
Frontiers Media S.A.
2023-07-01
|
Sarja: | Frontiers in Molecular Neuroscience |
Aiheet: | |
Linkit: | https://www.frontiersin.org/articles/10.3389/fnmol.2023.1231659/full |